The authors present the results of the first four stages of research conducted under Government Contract No.
02.740.11.0774: Development of a Technology for Molecular Diagnostics of the Individual Genetic Risk of Development of
Reproductive Function Disorders Associated with Human Urogenital Chlamydial Infection.
Канищева Е.Ю. Воспалительные заболевания органов малого таза у женщин и их связь с инфекциями, передаваемыми половым путем. Диагностика, лечение. Вестн. дерматол. и венерол. 2002; 4: 16-23.
Moss T.R., Darougar R. (2001): Human genital infections with C. trachomatis.
Kamwendo F., Forslin L., Bodin L. et al. Decreasing incidences of gonorrhea- and chlamydiaassociated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transmit Dis 1996; 23: 384-91.
Öhman H., Triitinen A., Halttunen M., et al. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes and Immunity 2006; 7: 243-249.
Rasouli M., Kiany S. Association of interferongamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis. Cytokine 2007; 38: 49-53.
Mei В., Luo Q., Du K. et al., Association of MICA gene polymorphisms with Chlamydia trachomatis infection and related tubal pathology in infertile woman. Hum Reprog 2009 Dec; 24 (12): 3090-5.
Sziller I., Babula O., Ujházy A. et al. Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum Reprod 2007; 22 (7): 1861-5.
Moore K.W., R de Waal Malefyt R. L. Coffman and A. O'Garra. Interleukin-10 and interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683- 765.
Rotterberg M.E., Gigliotti-Rothfunchs A., Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol - 2002; 14: 444-451.
Reddy B.S., Rastogi S., Das B. et al. Cytokyne expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication of T-cell responses. Clin Exp Immunol 2004; 137: 552-558.
Srivastva P., Jha R., Bas S. In in fertile women, cells from Chlamydia trachomatis infected site release higher levels of interferon-gamma, interleikin-10 and tumor necrosis factoralpha upon heat shock protein stimulation then fertile women. Biology and Endocrinology 2008; 6: 20.
Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986; Apr 17-23; 320 (6063): 584-8.
Pacheco A.G., Cardoso C.C., Moraes M.O. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polmorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet. 2008 Jun;123 (5): 477-84.
Boraska V., Skrabić V., Culić V.C. et al. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol Res. 2008; 41 (2): 157-63.
Witte J.S., Palmer L.J., O'Connor R.D. et al. Relation between tumour necrosis factor polymorphism TNF- αlpha-308 and risk of asthma. Eur J Hum Genet. 2002 Jan; 10 (1): 82-5.
Banno T., Gazel A., Blumenberg M. Effects of tumor necrosis factor-alpha (TNF-alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004; 279: 32633-42.
Turner D.M., Williams D.M., Sankaran D. et al. An investigation of polymorphism in the interleukin- 10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
Natividad A., Holland M.J., Rockett K.A. et al. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet 2008; 17: 323-9.
Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180: 5771-7.
Bierie B., Moses H.L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 2010 Feb; 21 (1): 49-59. Epub 2009 Dec 16.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор). Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.
This website uses cookies
You consent to our cookies if you continue to use our website.